Koyfin Home > Directory > Health Care > Antares Pharma > Cash from Investing Activities

Antares Pharma Cash from Investing Activities Chart (ATRS)

Antares Pharma annual/quarterly Cash from Investing Activities from 2000 to 2018.
  • Antares Pharma Cash from Investing Activities for the quarter ending September 09, 2018 was $0m a 3,225.79% decrease of -7m year over year
  • Antares Pharma Cash from Investing Activities for the last 12 months ending September 09, 2018 was $19m a 123.37% increase of 23m year over year
  • Antares Pharma Annual Cash from Investing Activities for 2017 was $-4m a 330.73% decrease of -14m from 2016
  • Antares Pharma Annual Cash from Investing Activities for 2016 was $10m a 257.35% increase of 26m from 2015
  • Antares Pharma Annual Cash from Investing Activities for 2015 was $-16m a 216.68% decrease of -34m from 2014
Other Cash Flow Metrics:
  • Antares Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $0m a -9,658.63% increase of 8m year over year
  • Antares Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $0m a -10,730.73% increase of 6m year over year
  • Antares Pharma Total Revenue for the quarter ending December 12, 2018 was $19m a 32.51% increase of 6m year over year
View Chart On Koyfin

Quarterly ATRS Cash from Investing Activities Data

09/2018$0m
06/2018$9m
03/2018$3m
12/2017$7m
09/2017$0m
06/2017$-10m
03/2017$0m
12/2016$2m
09/2016$4m
06/2016$2m

Annual ATRS Cash from Investing Activities Data

2017$-4m
2016$10m
2015$-16m
2014$18m
2013$0m
2012$-22m
2011$-16m
2010$0m
2009$0m
2008$14m